Juan Carlos Galán Montemayor-rekin lankidetzan egindako argitalpenak (12)

2014

  1. Recombination blurs phylogenetic groups routine assignment in Escherichia coli: Setting the record straight

    PLoS ONE, Vol. 9, Núm. 8

2013

  1. Normal Mutation Rate Variants Arise in a Mutator (Mut S) Escherichia coli Population

    PLoS ONE, Vol. 8, Núm. 9

  2. Population structure and Antimicrobial susceptibility of both nonpersistent and persistent Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients

    Journal of Clinical Microbiology, Vol. 51, Núm. 8, pp. 2761-2765

2011

  1. In vitro selection of variants resistant to β-lactams plus β-lactamase inhibitors in CTX-M β-lactamases: Predicting the in vivo scenario?

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 10, pp. 4530-4536

2010

  1. Polymorphic mutation frequencies of clinical and environmental Stenotrophomonas maltophilia populations

    Applied and Environmental Microbiology, Vol. 76, Núm. 6, pp. 1746-1758

2007

  1. Mutation rate is reduced by increased dosage of mutL gene in Escherichia coli K-12

    FEMS Microbiology Letters, Vol. 275, Núm. 2, pp. 263-269

2005

  1. Increased mutation frequencies in Escherichia coli isolates harboring extended-spectrum β-lactamases

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 11, pp. 4754-4756

2004

  1. Fosfomycin and rifampin disk diffusion tests for detection of Escherichia coli mutator strains

    Journal of Clinical Microbiology, Vol. 42, Núm. 9, pp. 4310-4312

  2. Polymorphic mutation frequencies in Escherichia coli: Emergence of weak mutators in clinical isolates

    Journal of Bacteriology, Vol. 186, Núm. 16, pp. 5538-5542

2003

  1. Erratum: Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation (Antimicrobial Agents and Chemotherapy (2003) 47:4 (1464-1467))

    Antimicrobial Agents and Chemotherapy

  2. Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation

    Antimicrobial Agents and Chemotherapy, Vol. 47, Núm. 4, pp. 1464-1467

  3. Haemophilus influenzae blaROB-1 mutations in hypermutagenic ΔampC Escherichia coli conferring resistance to cefotaxime and β-lactamase inhibitors and increased susceptibility to cefaclor

    Antimicrobial Agents and Chemotherapy, Vol. 47, Núm. 8, pp. 2551-2557